WELLS FARGO & COMPANY/MN - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 23 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$39
-87.9%
187
-79.7%
0.00%
Q1 2023$322
+63.5%
919
+0.3%
0.00%
Q4 2022$197916
-8.9%
0.00%
Q3 2022$0
-100.0%
1,005
+0.9%
0.00%
Q2 2022$1,000
-50.0%
996
+2.9%
0.00%
Q1 2022$2,0000.0%968
+11.9%
0.00%
Q4 2021$2,000
-33.3%
8650.0%0.00%
Q3 2021$3,000
+50.0%
865
+5.1%
0.00%
Q2 2021$2,0000.0%823
+1.9%
0.00%
Q1 2021$2,000
+100.0%
808
+0.4%
0.00%
Q4 2020$1,000
-50.0%
805
+0.8%
0.00%
Q3 2020$2,000
+100.0%
799
+1.0%
0.00%
Q2 2020$1,0000.0%7910.0%0.00%
Q1 2020$1,000
-50.0%
791
+5.5%
0.00%
Q4 2019$2,000
+100.0%
7500.0%0.00%
Q3 2019$1,0000.0%750
+15.4%
0.00%
Q2 2019$1,000
-50.0%
6500.0%0.00%
Q1 2019$2,000
+100.0%
650
+160.0%
0.00%
Q4 2018$1,0002500.00%
Other shareholders

There were no reported owners of ADIAL PHARMACEUTICALS INC in Q1 2023.

NameSharesValueWeighting ↓
View complete list of ADIAL PHARMACEUTICALS INC shareholders